These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3797547)

  • 21. Effect of neuroleptic medication on cerebrospinal fluid monoamine metabolite concentrations in schizophrenia. Serotonin-dopamine interactions as a target for treatment.
    Kahn RS; Davidson M; Knott P; Stern RG; Apter S; Davis KL
    Arch Gen Psychiatry; 1993 Aug; 50(8):599-605. PubMed ID: 7688208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF.
    Nikisch G; Baumann P; Wiedemann G; Kiessling B; Weisser H; Hertel A; Yoshitake T; Kehr J; Mathé AA
    J Clin Psychopharmacol; 2010 Oct; 30(5):496-503. PubMed ID: 20814316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals.
    Hjärpe J; Söderman E; Andreou D; Sedvall GC; Agartz I; Jönsson EG
    Psychiatry Res; 2018 May; 263():30-34. PubMed ID: 29482043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced brain delivery of homovanillic acid to cerebrospinal fluid during human aging.
    Rapoport SI; Schapiro MB; May C
    Arch Neurol; 2004 Nov; 61(11):1721-4. PubMed ID: 15534183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between dopamine D2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and cerebrospinal fluid. A pilot study in patients suffering from first-episode schizophrenia treated with quetiapine.
    Nikisch G; Baumann P; Kiessling B; Reinert M; Wiedemann G; Kehr J; Mathé AA; Piel M; Roesch F; Weisser H; Schneider P; Hertel A
    J Psychiatr Res; 2010 Sep; 44(12):754-9. PubMed ID: 20176367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cortical and central atrophy in chronic schizophrenia. A controlled study.
    Okasha A; Madkour O
    Acta Psychiatr Scand; 1982 Jan; 65(1):29-34. PubMed ID: 7187173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computed tomography in schizophrenics and normal volunteers. I. Fluid volume.
    Jernigan TL; Zatz LM; Moses JA; Berger PA
    Arch Gen Psychiatry; 1982 Jul; 39(7):765-70. PubMed ID: 7165476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased homovanillic acid concentrations in cerebrospinal fluid in children without a known defect in dopamine metabolism.
    Van Der Heyden JC; Rotteveel JJ; Wevers RA
    Eur J Paediatr Neurol; 2003; 7(1):31-7. PubMed ID: 12615172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlates of lateral ventricular size in chronic schizophrenia, II: biological measures.
    Losonczy MF; Song IS; Mohs RC; Mathé AA; Davidson M; Davis BM; Davis KL
    Am J Psychiatry; 1986 Sep; 143(9):1113-8. PubMed ID: 2428259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between abnormal brainstem auditory-evoked potentials and subnormal CSF levels of HVA and 5-HIAA in first-episode schizophrenic patients.
    Lindström LH; Wieselgren IM; Klockhoff I; Svedberg A
    Biol Psychiatry; 1990 Sep; 28(5):435-42. PubMed ID: 1698468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebral atrophy and neuropsychological correlates in schizophrenia.
    Rossi A; de Cataldo S; Stratta P; Sabatini MD; Nistico R; De Donatis M; Casacchia M
    Acta Psychiatr Belg; 1987; 87():670-5. PubMed ID: 3452986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CSF dopamine turnover and positive schizophrenic symptoms after withdrawal of long-term neuroleptic treatment.
    Frecska E; Perényi A; Bagdy G; Révai K
    Psychiatry Res; 1985 Nov; 16(3):221-6. PubMed ID: 2868474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acetylcholinesterase activities and monoamine metabolite levels in the cerebrospinal fluid of patients with Alzheimer's disease.
    Kawakatsu S; Morinobu S; Shinohara M; Totsuka S; Kobashi K
    Biol Psychiatry; 1990 Sep; 28(5):387-400. PubMed ID: 1698467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A meta-analysis of homovanillic acid concentrations in schizophrenia.
    Tuckwell HC; Koziol JA
    Int J Neurosci; 1993 Nov; 73(1-2):109-14. PubMed ID: 8132411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral structural pathology in schizophrenia: evidence for a selective prefrontal cortical defect.
    Shelton RC; Karson CN; Doran AR; Pickar D; Bigelow LB; Weinberger DR
    Am J Psychiatry; 1988 Feb; 145(2):154-63. PubMed ID: 3277448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis. Implications for regional brain dysfunction in schizophrenia.
    Pickar D; Breier A; Hsiao JK; Doran AR; Wolkowitz OM; Pato CN; Konicki PE; Potter WZ
    Arch Gen Psychiatry; 1990 Jul; 47(7):641-8. PubMed ID: 1694425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-HIAA in cerebrospinal fluid and deficit schizophrenic characteristics.
    Csernansky JG; King RJ; Faustman WO; Moses JA; Poscher ME; Faull KF
    Br J Psychiatry; 1990 Apr; 156():501-7. PubMed ID: 1696842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variations of homovanillic acid levels in ventricular cerebrospinal fluid.
    Hildebrand J; Moussa Z; Raftopoulos C; Vanhouche J; Laute MA; Przedborski S
    Acta Neurol Scand; 1992 May; 85(5):340-2. PubMed ID: 1621497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlations between aminergic metabolites simultaneously obtained from human CSF and brain.
    Stanley M; Traskman-Bendz L; Dorovini-Zis K
    Life Sci; 1985 Oct; 37(14):1279-86. PubMed ID: 2413327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The significance of homovanillic acid and 3,4-dihydroxyphenylacetic acid concentrations in human lumbar cerebrospinal fluid.
    Ebinger G; Michotte Y; Herregodts P
    J Neurochem; 1987 Jun; 48(6):1725-9. PubMed ID: 3572399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.